Real-Life Clinical Implementation and Validation of a Strategy Based on Cmv-Specific Cell-Mediated Immunity to Guide Cmv Preventive Therapy in Kidney Transplantation

被引：0
|
作者：
Kervella, D. [1 ]
Cidraque, I. [1 ]
Crespo, E. [1 ]
Donadeu, L. [1 ]
Torija, A. [1 ]
Meneghini, M. [1 ]
Moreso, F. [1 ]
Melilli, E. [2 ]
Montero, N. [2 ]
Blanchard, T. [3 ]
Kotton, C. [4 ]
Kumar, D. [5 ]
Bestard, O. [1 ]
机构：
[1] Vall DHebron Univ Hosp, Translat Transplant Ctr, Barcelona, Spain
[2] Bellvitge Univ Hosp, Barcelona, Spain
[3] Oxford Immunotec, Marlborough, MA USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Univ Hlth Network, Toronto, ON, Canada
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
523
引用
收藏
页码：S587 / S588
页数：2
相关论文
共 39 条
  • [21] Pre-Transplant CMV-Specific T-Cell Immunity Is an Additional Independent Variable Predicting CMV Infection After Kidney Transplantation
    Crespo, E.
    Jarque, M.
    Luque, S.
    Melilli, E.
    Manonelles, A.
    Gil-Vernet, S.
    Cruzado, J.
    Grinyo, J.
    Bestard, O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 216 - 217
  • [22] CMV-Specific Cell-Mediated Immunity Early after Transplantation Discriminates R plus Transplant Patients at Risk of CMV Infection among Different Solid Organ Transplants.
    Jarque, M.
    Cachero, A.
    Garcia-Romero, E.
    Llado, L.
    Baliellas, C.
    Diez, C.
    Melilli, E.
    Fabregat, J.
    Gonzalez-Costello, J.
    Bestard, O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 753 - 753
  • [23] Pretransplant CMV-Specific T-Cell Immunity But Not Dose of Antithymocyte Globulin Is Associated With Recovery of Specific Immunity After Kidney Transplantation
    Paez-Vega, Aurora
    Cantisan, Sara
    Aguera, Maria L.
    Suner, Marta
    Facundo, Carmen
    Yuste, Jose R.
    Fernandez-Ruiz, Mario
    Montejo, Miguel
    Redondo-Pachon, Dolores
    Lopez-Oliva, Maria O.
    Fernandez-Rodriguez, Ana
    Farinas, Maria C.
    Hernandez, Domingo
    Len, Oscar
    Munoz, Patricia
    Valle-Arroyo, Jorge
    Rodelo-Haad, Cristian
    Cordero, Elisa
    Torre-Cisneros, Julian
    JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (07): : 1205 - 1213
  • [24] Diagnostic Performance of Two Different Techniques to Quantify CMV-Specific Cell-Mediated Immunity in Intermediate-Risk Seropositive Kidney Transplant Recipients
    Fernandez-Ruiz, Mario
    Nuevalos, Marcos
    Rodriguez-Goncer, Isabel
    Garcia-Rios, Estefani
    Ruiz-Merlo, Tamara
    Redondo, Natalia
    Trujillo, Hernando
    Gonzalez, Esther
    Polanco, Natalia
    Caso, Jose Maria
    Aparicio-Minguijon, Eduardo
    Lopez-Medrano, Francisco
    San Juan, Rafael
    Andres, Amado
    Perez-Romero, Pilar
    Aguado, Jose Maria
    TRANSPLANT INFECTIOUS DISEASE, 2025,
  • [25] Monitoring of CMV-specific cell-mediated immunity with a commercial ELISA-based interferon-γ release assay in kidney transplant recipients treated with antithymocyte globulin
    Fernandez-Ruiz, Mario
    Rodriguez-Goncer, Isabel
    Parra, Patricia
    Ruiz-Merlo, Tamara
    Corbella, Laura
    Lopez-Medrano, Francisco
    Polanco, Natalia
    Gonzalez, Esther
    San Juan, Rafael
    Dolores Folgueira, Maria
    Andres, Amado
    Maria Aguado, Jose
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (08) : 2070 - 2080
  • [26] Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection
    Chiereghin, Angela
    Potena, Luciano
    Borgese, Laura
    Gibertoni, Dino
    Squarzoni, Diego
    Turello, Gabriele
    Petrisli, Evangelia
    Piccirilli, Giulia
    Gabrielli, Liliana
    Grigioni, Francesco
    Lazzarotto, Tiziana
    JOURNAL OF CLINICAL MICROBIOLOGY, 2018, 56 (04)
  • [27] CMV-specific Cell-mediated Immunity at 3-month Prophylaxis Withdrawal Discriminates D plus /R plus Kidney Transplants at Risk of Late-onset CMV Infection Regardless the Type of Induction Therapy
    Jarque, Marta
    Melilli, Edoardo
    Crespo, Elena
    Manonelles, Anna
    Montero, Nuria
    Torras, Joan
    Cruzado, Josep M.
    Luque, Sergi
    Gil-Vernet, Salvador
    Grinyo, Josep M.
    Bestard, Oriol
    TRANSPLANTATION, 2018, 102 (11) : E472 - E480
  • [28] T-Cell Depletion Does Not Increase the Risk of CMV Infection in Donor-Positive, Recipient-Negative Kidney Transplants Due to the Absence of Preformed CMV-Specific Cell-Mediated Immunity.
    Jarque, M.
    Kaminski, H.
    Couzi, L.
    Crespo, E.
    Dechanet-Merville, J.
    Luque, S.
    Montero, N.
    Pascual, M.
    Manuel, O.
    Merville, P.
    Bestard, O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 320 - 320
  • [29] Comparison of intracellular cytokine staining versus an ELISA-based assay to assess CMV-specific cell-mediated immunity in high-risk kidney transplant recipients
    Fernandez-Ruiz, Mario
    Redondo, Natalia
    Parra, Patricia
    Ruiz-Merlo, Tamara
    Rodriguez-Goncer, Isabel
    Polanco, Natalia
    Gonzalez, Esther
    Lopez-Medrano, Francisco
    San Juan, Rafael
    Navarro, David
    Andres, Amado
    Maria Aguado, Jose
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (04)
  • [30] An optimized IFN-γ ELISpot assay using T-activated® proteins for determination of CMV-specific cell-mediated immunity
    Boeckl, Katharina
    Koerber, Nina
    Barabas, Sascha
    Demi, Ludwig
    Bauer, Tanja
    JOURNAL OF IMMUNOLOGY, 2016, 196
1234